- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Antifibrotic Therapies in the Liver ; volume:35 ; number:02 ; year:2015 ; pages:184-198
Seminars in liver disease ; 35, Heft 02 (2015), 184-198
- Beteiligte Personen und Organisationen
-
Mehal, W. Z.
Schuppan, D.
- DOI
-
10.1055/s-0035-1550055
- URN
-
urn:nbn:de:101:1-2019011109480190791657
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mehal, W. Z.
- Schuppan, D.
Ähnliche Objekte (12)
Antifibrotic therapies to control cardiac fibrosis
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis : potential implications for antifibrotic therapies
Novel regional therapies for liver tumors
Antifibrotic effects of an sGC activator in rat models of liver fibrosis
Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies
The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis
Antifibrotic therapy to normalize the tumor microenvironment
Noncolorectal, Nonneuroendocrine Liver Metastases : Diagnosis and Current Therapies
Antifibrotic therapy in the liver by adenovirus mediated expression of a TGF β1 [beta 1] antisense mRNA
Antifibrotic therapies to control cardiac fibrosis
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis : potential implications for antifibrotic therapies
Novel regional therapies for liver tumors
Antifibrotic effects of an sGC activator in rat models of liver fibrosis
Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies
The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis
Antifibrotic therapy to normalize the tumor microenvironment
Noncolorectal, Nonneuroendocrine Liver Metastases : Diagnosis and Current Therapies
Antifibrotic therapy in the liver by adenovirus mediated expression of a TGF β1 [beta 1] antisense mRNA
Antifibrotic therapies to control cardiac fibrosis
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis : potential implications for antifibrotic therapies
Novel regional therapies for liver tumors
Antifibrotic effects of an sGC activator in rat models of liver fibrosis
Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies
The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis
Antifibrotic therapy to normalize the tumor microenvironment
Noncolorectal, Nonneuroendocrine Liver Metastases : Diagnosis and Current Therapies